The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication by Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau

“…**Background:** Few studies have attempted to assess the effectiveness of formulary management in reducing the antipsychotic costs and utilization across U.S. state Medicaid programs, despite concerns about the potential impact of such formulary management on Medicaid patient health outcomes. …”
Get full text